Renal impairment: Patients with impaired renal function do not generally require dose reduction unless impairment is severe; do not administer extended-release product in patients with CrCl <30 mL/min. GFR <30 mL/min: Should not receive 875 mg (immediate release) or 775 mg (extended release)